MedTrace Logo

Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes

NCT00687063 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10008

Last updated 2023-11-02

No results posted yet for this study

Summary

The study is conducted in Asia. The aim of this observational study is to evaluate the weight change from baseline while using Levemir® in subjects with type 2 diabetes mellitus under normal clinical practice conditions in India.

Conditions

Interventions

DRUG

insulin detemir

Start dose and frequency of insulin detemir is to be decided by physician. The choice of patient is also at the discretion of Physician

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452), MD · Novo Nordisk A/S

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2009-02-28
Completion
2009-02-28

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00687063 on ClinicalTrials.gov